Published in J Clin Invest on August 01, 1959
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid. Eur J Clin Pharmacol (2007) 1.20
New responsibilities for health departments and public health nurses in tuberculosis-- keeping the outpatient on therapy. Am J Public Health Nations Health (1966) 1.12
The realized and unrealized benefits from chemotherapy for Tuberculosis. Public Health Rep (1967) 0.90
Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients. J Clin Invest (1959) 0.79
Antimicrobial therapy of pulmonary tuberculosis. Bull World Health Organ (1960) 0.78
Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health (1958) 3.71
Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc (1954) 2.98
The role of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis. J Bacteriol (1955) 2.60
Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953. Br Med J (1958) 2.27
Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest (1959) 2.20
Sputkm conversion and the metabolism of isoniazid. Am Rev Tuberc (1958) 1.49
Chemotherapy of tuberculosis. Adv Intern Med (1956) 1.21
Effect of para-aminosalicylic acid on serum isoniazid levels in man. Proc Soc Exp Biol Med (1956) 1.16
Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. Am J Med Sci (1957) 1.16
Changing concepts in the treatment of pulmonary tuberculosis. Ann Intern Med (1957) 1.16
The effect of isoniazid on growing and resting tubercle bacilli. Am Rev Tuberc (1954) 1.01
Prognosis of persistent cavitation in sputum-negative cases of tuberculosis following long-term chemotherapy. Tubercle (1958) 0.96
Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med (1956) 0.95
Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients. J Clin Invest (1959) 0.93
Virulence of tubercle bacilli recovered from patients treated with isoniazid. Am Rev Tuberc (1954) 0.85
The problem of resection surgery for pulmonary tuberculosis in the noninfectious patient with persisting cavitary disease. Am Rev Tuberc (1956) 0.83
Open healing of tuberculous cavities; results in 40 patients treated conservatively. Br Med J (1958) 0.82
Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients. J Clin Invest (1959) 0.79
Specific serum agglutination of erythrocytes sensitized with extracts of tubercle bacilli. J Exp Med (1948) 11.08
Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis (1963) 9.11
Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health (1958) 3.71
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am Rev Tuberc (1954) 3.36
An apparatus for airborne infection of mice. Proc Soc Exp Biol Med (1952) 3.07
Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc (1954) 2.98
Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants. Am Rev Tuberc (1954) 2.62
The role of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis. J Bacteriol (1955) 2.60
A hemolytic modification of the hemagglutination test for antibodies against tubercle bacillus antigens. J Clin Invest (1950) 2.46
Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science (1953) 2.29
Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest (1959) 2.20
Cytochemical reaction of virulent tubercle bacilli. Am Rev Tuberc (1948) 2.14
Antigens of tubercle bacillus involved in hemagglutination and hemolysis reactions. Bull N Y Acad Med (1952) 1.98
Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc (1952) 1.93
The effect of wetting agents on the growth of tubercle bacilli. J Exp Med (1948) 1.90
Interface enrichment of methylene blue by fatty acids with microanalytic applications. Science (1957) 1.84
Immunological aspects of airborne infection: reactions to inhaled antigens. Bacteriol Rev (1961) 1.72
Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro. Am Rev Tuberc (1954) 1.63
INFECTIVITY, PATHOGENICITY AND SULPHOLIPID FRACTION OF SOME INDIAN AND BRITISH STRAINS OF TUBERCLE BACILLI. Tubercle (1963) 1.43
The experimental analysis of virulence of tubercle bacilli. Bull N Y Acad Med (1950) 1.36
The hemagglutination test in tuberculosis. Am Rev Tuberc (1950) 1.35
The effects of some sulfhydryl compounds on growth of catalase-positive and catalase-negative tubercle bacilli. Am Rev Tuberc (1956) 1.35
Peripheral neuritis in tuberculous patients treated with isoniazid. Am Rev Tuberc (1954) 1.29
Studies on the gaseous content of tuberculous cavities. Am Rev Respir Dis (1959) 1.29
[A case of human infection by Mycobacterium ulcerans in the western hemisphere; preliminary note]. Int J Lepr (1954) 1.24
Chemotherapy of tuberculosis. Adv Intern Med (1956) 1.21
Changing concepts in the treatment of pulmonary tuberculosis. Ann Intern Med (1957) 1.16
Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. Am J Med Sci (1957) 1.16
Effect of para-aminosalicylic acid on serum isoniazid levels in man. Proc Soc Exp Biol Med (1956) 1.16
Airborne immunization against tuberculosis. Science (1958) 1.13
Implications of the phenomenon of open cavity healing for the chemotherapy of pulmonary tuberculosis. Am Rev Tuberc (1955) 1.13
Techniques of drug-resistance tests. Am Rev Tuberc (1954) 1.12
Diagnosis of tight mitral stenosis. J Am Med Assoc (1952) 1.11
The permeability of the Douglas-type bag to respiratory gases. J Lab Clin Med (1953) 1.11
Infectivity and pathogenicity of Indian and British strains of tubercle bacilli studied by aerogenic infection of guinea pigs. Am Rev Respir Dis (1963) 1.10
Observations on the pathogenicity of isoniazid-resistant mutants of tubercle bacilli for tuberculous patients. Am Rev Tuberc (1955) 1.06
Isoniazid as a cause of optic neuritis and atrophy. J Am Med Assoc (1957) 1.06
The effect of mild exercise in the supine position on the pulmonary arterial pressure of five normal human subjects. J Clin Invest (1954) 1.04
Clinical evaluation of isoniazid. Am Rev Tuberc (1954) 1.02
Dosages of isoniazid and streptomycin for routine chemotherapy of tuberculosis. Tubercle (1960) 0.99
Tuberculin hypersensitivity in tuberculous infants treated with isoniazid. N Engl J Med (1955) 0.98
Comparative study of the vaccinating properties of BCG and its isoniazid-resistant mutant in guinea pigs. Am Rev Tuberc (1957) 0.97
Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med (1956) 0.95
Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients. J Clin Invest (1959) 0.93
A histologic study of the blood vessels in surgically resected tuberculous lungs. Am Rev Tuberc (1951) 0.91
Treatment of broncho-pulmonary moniliasis by dye inhalation. Dis Chest (1952) 0.91
Carbon dioxide-impermeable plastic bags for artificial cultivation of tubercle bacilli. Am Rev Respir Dis (1963) 0.90
The effect of breathing 100% oxygen on the pulmonary arterial pressure in patients with pulmonary tuberculosis and mitral stenosis. J Clin Invest (1952) 0.90
An evaluation of three drugs alleged to relieve airway obstruction in asthmatic patients. Curr Ther Res Clin Exp (1961) 0.89
An apparatus for exercising a patient in the recumbent position. J Lab Clin Med (1950) 0.88
Cor pulmonale associated with symptoms and signs of asthma in children. Pediatrics (1959) 0.88
Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes. J Am Med Assoc (1955) 0.87
Media for tubercle bacilli. Am Rev Tuberc (1947) 0.87
The status of the adrenal gland in the asthmatic patient. Am J Med Sci (1960) 0.84
The case against compulsory isolation of the recalcitrant tuberculous. R I Med J (1959) 0.84
The handling of the poor risk patient with pulmonary tuberculosis: antimicrobial therapy, cardio-pulmonary function and surgery. Dis Chest (1956) 0.82
Quantitative inhalation challenge in allergic asthma. J Allergy (1963) 0.81
DYNAMIC ASPECTS OF THE STERILIZING ACTION OF ISONIAZID ON MYCOBACTERIUM TUBERCULOSIS. Am Rev Respir Dis (1963) 0.81
Experimental penicillin prophylaxis of staphylococcal infection in rabbits. Proc Soc Exp Biol Med (1960) 0.80
Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients. J Clin Invest (1959) 0.79
The relationship between periarteritis nodosa and sarcoidosis. Ann Intern Med (1953) 0.79
Fatal tuberculous meningitis developing during isoniazid-streptomycin therapy. Am Rev Tuberc (1955) 0.79
Severe reactive pulmonary hypertension secondary to aortic stenosis. Am J Med Sci (1961) 0.79
Ambulation of patients with pulmonary tuberculosis under protection of chemotherapy; a preliminary report. Am Rev Tuberc (1954) 0.79
Chemoprophylaxis with isoniazid against aerogenic tuberculous infection in the guinea pig. Am Rev Respir Dis (1962) 0.77
Laboratory aids to diagnosis and therapy. Annu Rev Med (1954) 0.76
Sarcoidosis: a hypersensitivity disease, discussion of three cases. J Allergy (1954) 0.76
Factors involved in the recovery of a patient after prolonged ventricular fibrillation during hypothermia. J Thorac Surg (1958) 0.76
Atrial septal defect experiences in the clinical evaluation of 15 consecutive cases of the secundum variety. Am J Med Sci (1959) 0.75
Endocarditis following ventricular septal defect repair. Calif Med (1958) 0.75
Chemotherapy of childhood tuberculosis. Am J Dis Child (1961) 0.75
Effect of increasing dosage of streptomycin sulfate on serum levels of antimicrobially active drug. Dis Chest (1961) 0.75
The residual lesion in pulmonary tuberculosis requiring surgery. A review of 100 sputum-negative patients consecutively operated on. N Engl J Med (1960) 0.75
Medical treatment of tuberculosis: preliminary report on early ambulation of tuberculous patients under the cover of chemotherapy. Trans Annu Meet Natl Tuberc Assoc (1954) 0.75
Comparative susceptibilities of different strains of mice to experimental infection with mammalian tubercle bacilli. J Bacteriol (1947) 0.75